Grimholt Runa M, Harteveld Cornelis L, Arkesteijn Sandra G J, Fjeld Bente, Klingenberg Olav
a Department of Medical Biochemistry , Oslo University Hospital , Oslo , Norway.
b Faculty of Medicine , University of Oslo , Oslo , Norway.
Hemoglobin. 2018 Mar;42(2):126-128. doi: 10.1080/03630269.2018.1473255. Epub 2018 Jul 26.
Sequence variants located in the introns of the β-globin gene may affect the mRNA processing and cause β-thalassemia (β-thal). Sequence variants that change one of the invariant dinucleotides at the exon-intron boundaries may have fatal consequences for normal mRNA splicing. Intronic variants located far from obvious regulatory sequences can be more difficult to evaluate. There is a potential for misinterpretation of such sequence variants. Hence, thorough evaluation of patient data together with critical use of databases and in silico prediction tools are important. Here, we describe two rare sequence variants in the second intron of the β-globin gene, HBB: c.316-70C>G and HBB: c.316-125A>G (NM_000518.4), both previously reported as variants causing β-thal, and later as benign sequence variants. Due to the limited number of published cases and inconsistent interpretations, the significance of these sequence variants has been unclear. We have identified these two sequence variants in multiple individuals, alone and in a variety of combinations with other δ- and β-globin defects, and we find no influence of the sequence variants on the phenotype.